What it is
Selank is a synthetic heptapeptide analogue of tuftsin. It is registered in a limited number of jurisdictions and is not a registered medicine in South Africa.
The Range
SK5 · Pen · Neuroscience research
Selank 5 mg pen
Status varies — confirm locallyEvidence: Insufficient
A synthetic analogue of the immunomodulatory peptide tuftsin, studied in anxiety-related and neuroimmune research contexts.
Evidence highlights
Mechanism being studied
Preclinical descriptions include modulation of GABAergic and monoaminergic signalling and effects on immune-related mediators.
Human evidence
Available human studies are small and largely from a narrow set of research groups. Evidence is insufficient to support general clinical conclusions.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.